@article {Abell2023.02.05.23285483, author = {Isobel Abell and Cameron Zachreson and Eamon Conway and Nicholas Geard and Jodie McVernon and Thomas Waring and Christopher Baker}, title = {Rapid prototyping of models for COVID-19 outbreak detection in workplaces}, elocation-id = {2023.02.05.23285483}, year = {2023}, doi = {10.1101/2023.02.05.23285483}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Early case detection is critical to preventing onward transmission of COVID-19 by enabling prompt isolation of index infections, and identification and quarantining of contacts. Timeliness and completeness of ascertainment depend on the surveillance strategy employed. We use rapid prototype modelling to quickly investigate the effectiveness of testing strategies, to aid decision making. Models are developed with a focus on providing relevant results to policy makers, and these models are continually updated and improved as new questions are posed. The implementation of testing strategies in high risk settings in Australia was supported using models to explore the effects of test frequency and sensitivity on outbreak detection. An exponential growth model is firstly used to demonstrate how outbreak detection changes with varying growth rate, test frequency and sensitivity. From this model we see that low sensitivity tests can be compensated for by high frequency testing. This model is then updated to an Agent Based Model, which was used to test the robustness of the results from the exponential model, and to extend it to include intermittent workplace scheduling. These models help our fundamental understanding of disease detectability through routine surveillance in workplaces and evaluate the impact of testing strategies and workplace characteristics on the effectiveness of surveillance. This analysis highlights the risks of particular work patterns while also identifying key testing strategies to best improve outbreak detection in high risk workplaces.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Australian Government Department of Health and Ageing Office of Health Protection.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code used to generate all results in this manuscript is available online https://github.com/iabell/rapid_prototyping_covid_19}, URL = {https://www.medrxiv.org/content/early/2023/02/07/2023.02.05.23285483}, eprint = {https://www.medrxiv.org/content/early/2023/02/07/2023.02.05.23285483.full.pdf}, journal = {medRxiv} }